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Summary
Epsilon toxin (ET) is produced by Clostridium
perfringens types B and D and causes severe
neurological disorders in animals. ET has been
observed binding to white matter, suggesting that it
may target oligodendrocytes. In primary cultures
containing oligodendrocytes and astrocytes, we
found that ET (10−9 M and 10−7 M) binds to
oligodendrocytes, but not to astrocytes. ET
induces an increase in extracellular glutamate, and
produces oscillations of intracellular Ca2+ concen-
tration in oligodendrocytes. These effects occurred
without any change in the transmembrane resist-
ance of oligodendrocytes, underlining that ET acts
through a pore-independent mechanism. Pharma-
cological investigations revealed that the Ca2+
oscillations are caused by the ET-induced rise in
extracellular glutamate concentration. Indeed, the
blockade of metabotropic glutamate receptors type
1 (mGluR1) prevented ET-induced Ca2+ signals.
Activation of the N-methyl-D-aspartate receptor
(NMDA-R) is also involved, but to a lesser extent.
Oligodendrocytes are responsible for myelinating
neuronal axons. Using organotypic cultures of
cerebellar slices, we found that ET induced the
demyelination of Purkinje cell axons within 24 h.
As this effect was suppressed by antagonizing
mGluR1 and NMDA-R, demyelination is therefore
caused by the initial ET-induced rise in
extracellular glutamate concentration. This study
reveals the novel possibility that ET can act on
oligodendrocytes, thereby causing demyelination.
Moreover, it suggests that for certain cell types
such as oligodendrocytes, ET can act without
forming pores, namely through the activation of an
undefined receptor-mediated pathway.
Introduction
The proliferation of Clostridium perfringens types B and
D in the gut often causes lethal enterotoxaemia in
sheep, goats and other ruminants, and the main
aetiologic factor of the disease is epsilon toxin (ET),
a ∼ 30 kD peptide (reviewed in McClane et al., 2006;
Uzal and Songer, 2008; Bokori-Brown et al., 2011;
Popoff, 2011). The high lethality of ET (∼ 400,000 mouse
lethal doses per mg protein, intra-peritoneal) ranks this
toxin among the four most potent poisonous substances
known so far (reviewed in Gill, 1982).
To date, very little information is available about the
mechanisms involved in ET-induced intoxicated host
death during the naturally occurring disease. ET produced
in the intestinal lumen crosses the intestinal mucosal
barrier and disseminates throughout all organs via the
blood flow. Consistent with the severe neurological disor-
ders displayed during ruminant enterotoxaemia (reviewed
in Wioland et al., 2013), ET accumulates preferentially in
the brain and kidneys (Nagahama and Sakurai, 1991). In
rodents, ET binds to the luminal surface of the vascular
endothelium (Soler-Jover et al., 2007) and alters the
blood–brain barrier (Zhu et al., 2001; Soler-Jover et al.,
2007), favouring the formation of perivascular oedemas
and toxin diffusion into neural tissue. The nervous tissue
lesions are located in the cerebellum, and certain defined
cerebral regions, and overall, the cerebellum is a site of
predilection for the induction of early central nervous
system alterations (reviewed in Finnie, 2004; Wioland
et al., 2013).
Growing evidence indicates that the numerous neuro-
logical disorders caused by ET result from neural tissue
damages caused by the formation of brain oedemas
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cellular microbiology
(Buxton and Morgan, 1976; Uzal and Kelly, 1997; Uzal
et al., 1997) and/or the direct attack of some types of
neural cells by ET. Indeed, we have shown in earlier
studies that ET induces many effects in certain mouse
neuron types such as cerebellar granule cells, but does
not affect the glial cells of the astrocyte lineage
(Lonchamp et al., 2010; Wioland et al., 2013). Several
observations support the hypothesis that oligoden-
drocytes, whose protusions form the myelin sheath
around the axons in white matter, are potential major
targets for ET. Indeed, the central nervous system white
matter is the prominent tissue component labelled by
green fluorescent protein (GFP)-tagged ET in several
species such as sheep, cattle, mice and humans
(Dorca-Arévalo et al., 2008), and it is altered in infected
animals (Buxton and Morgan, 1976; Finnie, 1984a,b; Uzal
and Kelly, 1997; Uzal et al., 1997). Studies by Soler-Jover
et al. (2007); Dorca-Arévalo et al. (2008) and Lonchamp
et al. (2010) have found that ET co-localizes with myelin
markers like myelin basic protein (MBP) or 2′,3′-cyclic
nucleotide 3′-phosphodiesterase, both of which are
proteins specifically expressed by oligodendrocytes.
However, whether the oligodendrocytes and white matter
are directly affected by ET remains to be established.
The cytotoxic effects of ET are believed to result from
the initial formation of transmembrane pores (reviewed in
Bokori-Brown et al., 2011; Popoff, 2011). The three-
dimensional structure of ET displays many similarities
with the pore-forming toxin aerolysin produced by
Aeromonas hydrophila (Cole et al., 2004). It is currently
suggested that seven ET monomers assemble on the
membrane surface to create a pre-pore complex that
inserts into the lipid bilayer, forming a transmembrane
pore (Robertson et al., 2011). The conductance of ET
pores is very high, ranging between 480 pS and 550 pS
(Petit et al., 2001; Nestorovich et al., 2010). This pore-
forming activity results in a dramatic decrease in the
transmembrane electrical resistance produced by ET, as
detected through the use of patch-clamp recordings in
renal collecting duct mpkCCDcl4 murine cells (Chassin
et al., 2007) and mouse cerebellar granule cells
(Lonchamp et al., 2010). ET leads to multiple cell mani-
festations as such as glutamate efflux from mouse cer-
ebellar granule cells (Lonchamp et al., 2010), higher
intracellular Ca2+ concentration ( [Ca2+]i ), membrane
swelling, loss of adenosine triphosphate (ATP), induction
of oncosis and cell death (Petit et al., 1997; 2001; 2003;
Chassin et al., 2007; Lonchamp et al., 2010). However,
the relationship between these effects and ET pore-
forming activity is not clear (Chassin et al., 2007;
Lonchamp et al., 2010).
This study aimed to investigate the effects of ET on
oligodendrocytes and myelin, in vitro. More specifically,
we sought to determine whether ET binds to white matter
in rat cerebellar slices and to oligodendrocytes in rat cer-
ebellar cortex primary cultures, to ascertain whether this
process induces glutamate efflux and intracellular oscilla-
tions in [Ca2+]i, and to establish whether it induces a loss
of electrical resistance in the membrane, thus assessing
the possibility of ET-forming pores in the latter. The use of
organotypic cultures of rat cerebellar slices makes long-
term in vitro exposure to ET possible, thus enabling us to
also explore the possibility of this toxin-inducing myelin
alteration.
Results
ET binds to white matter and oligodendrocytes in rat
cerebellar slices
Acute cerebellar slices from (P25–P30) rats were incu-
bated for 5 min with ET (10−7 M) before fixation and
immunorevelation of bound ET. Figure 1A (green stain-
ing) shows no significant ET immunostaining in the
molecular (Fig. 1Ai and Aii) and Purkinje cell layers
[Fig. 1B; 28 kD protein (Calbindin) positive cells, red
colour], with the exception of some capillary vessels.
When similar experiments were performed without ET, a
very low-intensity and non-specific signal was found on
all cell types; this background signal is not illustrated.
Prominent ET immunosignal was found both in the
granular layer and in white matter. This rat white matter
labelling is reminiscent of previous observations in the
mouse cerebellum when ET (Lonchamp et al., 2010) or
GFP-tagged ET (Dorca-Arévalo et al., 2008) was used.
The marked ET-positive signal detected in the granular
layer (Fig. 1B) was mostly located on fibre-like structures
corresponding to myelinating protrusions of oligoden-
drocytes and myelinated axons. We observed a few cell
somata decorated by intense ET labelling (indicated by
arrow in Fig. 1B). These stained cells are too scarce to
correspond to granule cells, the density of which
exceeds 3.106 per mm3 in the granular layer (Palay and
Chan-Palay, 1974), and are probably oligodendrocyte
somata and/or ET-stained protrusions of the perineuronal
satellite oligodendrocytes that are wrapped around
certain granule cell somata (Takasaki et al., 2010). Con-
trary to previous observations made using mouse cer-
ebellum (Lonchamp et al., 2010; Wioland et al., 2013),
no ET binding was immunorevealed on rat granule cells.
The intense staining found in the cerebellar white matter
is consistent with previous reports showing that the white
matter in the central nervous system is the prominent
component labelled by ET or GFP-tagged ET in several
species (see Introduction). This, and the lack of detect-
able ET binding on granule cells, pinpoints the
oligodendrocytes as the only major cell target in rat cer-
ebellar tissue.
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ET binds to oligodendrocytes, but does not bind to
astrocytes in primary cultures of rat cerebellum
The ability of ET to bind to oligodendrocytes was exam-
ined on mixed primary cultures prepared from P0 to
P1 rat cerebellum and grown for four days. Mature
oligodendrocytes (as revealed by their positive im-
munoreactivity against MBP+ cells in Fig. 2) and
astrocytes (positive immunoreactivity against glial fibrillary
acidic protein, i.e. GFAP+ cells in Fig. 2) were the most
abundant cells (64–72% and 18–30% of total number of
cells respectively). Although oligodendrocytes cannot
grow in the absence of astrocytes, the two cell types did
not overlap each other in these cultures (Fig. 2Aiii)
(Gaillard and Bossu, 1995; Boussouf et al., 1997; Bernard
et al., 2001). Minor cell types were also present in the
primary culture, of which 5–8% were microglial cells [posi-
tive immunoreactivity against ionized calcium binding
adapter molecule 1 (Iba-1), data not shown] and 0.9–
1.5% were granule cells (as revealed by their typical
morphological shape and immunoreactivity against
microtubule associated protein-2).
ET labelled most oligodendrocytes (MBP+ cells in
Fig. 2B and C). When similar experiments were per-
formed without ET, no cell was stained (not illustrated).
Note the racket-shaped protrusions typical of mature-
myelinating oligodendrocytes (Fig. 2Bii, Cii). As this label-
ling was obtained using low ET concentration (10−9 M), it
is highly probable that oligodendrocytes express high-
affinity ET receptor(s). However, ET did not bind to all
oligodendrocytes (see Fig. 2D for an example of a MBP+/
ET-negative oligodendrocyte). Indeed, the number of
ET+ oligodendrocytes (i.e. significantly above the back-
ground signal) varied with the ET concentration used
(Fig. 2E). Incubation with 10−9 M, 10−8 M, or 10−7 M ET
yields 57.8%, 65.4% and 78.9% ET+ among the MBP+
cells respectively. These percentages were determined by
analysing ET staining on 500 MBP+ cells from five cul-
tures for the two lower toxin concentrations, and 1270
MBP+ cells from 10 distinct cultures for 10−7 M ET. This
indicates that oligodendrocytes are heterogeneous in
their ability to express ET receptors. We did not find any
ET binding to MBP-negative bipolar cells, and consider
that these cells are most probably the progenitor
oligodendrocytes (data not shown).
Using 10−7 M ET for 5 min, no astrocytes (i.e. GFAP+
cells) displayed significant ET immunolabelling, as deter-
mined from 927 GFAP+ cells in five cultures (Fig. 2F).
None of the microglial cells were stained by ET (data not
shown). In complete contrast with findings in intact rat
cerebellar slices (Fig. 1), the few contaminating granule
cells were marked by ET 10−7 M, but not at lower concen-
trations (not illustrated). Following the application of
10−7 M ET for 5 min to rat cerebellar primary cultures that
had been highly enriched in granule cells (prepared as
described by Lonchamp et al., 2010), all granule cells
Fig. 1. ET binds to rat cerebellar white matter.
A. ET immunostaining (green) obtained when cerebellar slices were incubated with 10−7 M ET for 5 min before fixation. Ai. Whole rat
cerebellum; scale bar = 500 μm. Aii. Magnification of region denoted by dotted frame in Ai, scale bar = 250 μm.
B. Cerebellar cortex was submitted to double immunostaining against ET (green) and the 28 kD protein (red), a Purkinje cell-specific marker.
The arrow denotes an oligodendrocyte soma decorated by ET, scale bar = 50 μm. WM, white matter; GCL, granule cell layer; ML, molecular
layer; PCL, Purkinje cell layer.
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were found to be ET+. These findings suggest that
although ET does not recognize rat granule cells in intact
neural tissue (Fig. 1), the latter still have the potential to
express ET receptors.
ET induces an increase in the extracellular glutamate
concentration by acting on oligodendrocytes
When injected intravenously or directly into the cerebral
tissue, ET triggers glutamate efflux (Miyamoto et al.,
1998; 2000). As this amino acid is present at a millimolar
concentration in the cytosolic compartment of all glial cell
types (reviewed by Nedergaard et al., 2002), extracellular
glutamate can originate from any cell type, provided it is
affected by ET. We examined the possibility that this
toxin induces glutamate release from oligodendrocytes.
Primary cultures were washed for 5 min with a physiologi-
cal medium containing no glutamate, then treated with
ET for 5 or 20 min (10−9 M: Fig. 3Ai; 10−7 M, Fig. 3Aii).
Figure 3A shows that exposure to 10−9 M or 10−7 M of ET
for 5 min induced a significant increase of up to ∼1.5
10−6 M in the extracellular concentration of glutamate
( [glutamate]e ), compared with the basal level values
(‘ctl’ bars in Fig. 3) obtained in untreated cells. The
[glutamate]e rise remained lower than that obtained by
osmotic cell lysis (‘lysis’ bars, Fig. 3). No further significant
increase was detected following incubation with ET for
20 min compared with the increase for 5 min incubation
(Fig. 3A, compare ‘ET5’ and ‘ET20’ bars), suggesting that
the rise in [glutamate]e reaches near completion in 5 min
or less.
To verify that the rise in [glutamate]e was specifically
due to ET and not to the presence of co-purified contami-
nants, we examined whether the change in [glutamate]e
could be prevented by neutralizing ET with the very
same specific anti-ET antibodies that we used for
immunorevealing ET binding (neutralization assessment
is described in the Material and Methods). No [glutamate]e
rise occurred when 10−9 M ET was pre-incubated with
antibodies at a 1 : 1 ratio for 20 min at room temperature
Fig. 2. ET binds to rat cerebellar
oligodendrocytes in co-culture containing
oligodendrocytes and astrocytes.
A. Rat cerebellar astrocytes and
oligodendrocytes present in co-cultures were
identified by their immunoreactivity to GFAP
(green, Ai) or MBP (red, Aii) respectively.
Aiii. Merge of GFAP and MBP
immunoreactivities, scale bar = 50 μm.
B–D. ET immunostaining of oligodendrocytes
obtained following application of ET (10−9 M,
B; 10−7 M, C) for 5 min before fixation.
Bi, Bii, Ci, and Cii. Immunostaining of ET
(green) and MBP (red). Biii, Ciii. Their merged
image. D. Same co-stainings, but showing an
example of an oligodendrocyte that was not
recognized by ET. A–C. Scale bars = 50 μm.
E. Bar chart reporting the fraction (%) of
MBP+ cells (i.e. oligodendrocytes) labelled by
ET following incubation with 10−9 M (%
determined from n = 500 MBP+ cells in five
different culture dishes), 10−8 M (% from
n = 500 MBP+ cells in five different culture
dishes), and 10−7 M (% from n = 1270 MBP+
cells in 10 different culture dishes) ET.
F. A typical example of lack of astrocyte
staining by ET following incubation of the
co-culture with the toxin (10−7 M) for 5 min
before fixation. Merged image of ET (green)
and GFAP (red) immunoreactivities. Scale
bar = 50 μm.
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(RT) before addition to the primary cultures (Fig. 3B). The
[glutamate]e rise is therefore a specific effect induced
by ET.
We next examined whether the ET effect on the
oligodendrocytes is the primary cause of the observed
[glutamate]e rise. To achieve this, primary cultures of
rat cerebellum, which contained astrocytes, but no
oligodendrocytes (see Material and Methods) were incu-
bated with ET (10−7 M, for 20 min). No significant change
was detected in [glutamate]e (Fig. 3C), indicating that the
rise in [glutamate]e is primarily due to a specific effect of ET
on oligodendrocytes. Cultured rat oligodendrocytes have a
high uptake capacity and affinity for glutamate (DeSilva
et al., 2009). Like astrocytes, they are able to release
glutamate in several circumstances, notably through
glutamate transporter reversal (reviewed by Danbolt,
2001; Nedergaard et al., 2002). We therefore investigated
if the blockade of the plasma membrane glutamate trans-
porters could interfere with ET action. DL-threo-beta-
benzyloxyaspartate (TBOA) is a well-characterized potent
blocker of all the glutamate transmembrane transporters
expressed by glial cells (Shimamoto et al., 1998; Domercq
and Matute, 1999; Danbolt, 2001; Pitt et al., 2003; DeSilva
et al., 2009). When TBOA (10−4 M) was applied to the
Fig. 3. ET induces increase in [glutamate]e.
A. [glutamate]e (μM) determined in cultures
containing oligodendrocytes and astrocytes
(co-cultures) in the absence of ET (ctl, open
bars), 5 min (dark grey bars) or 20 min (black
bars) after ET application at 10−9 M (Ai) or
10−7 M (Aii), or after cell lysis (light grey bars)
induced by hypo-osmotic shock.
B. The same after ET (10−9 M) application for
20 min, alone (black bar) or after
preincubation with specific anti-ET antibodies
(dark grey bars).
C. The same after ET (10−7 M) application to
cultures containing astrocytes, but not
oligodendrocytes.
D. [glutamate]e determined in control
conditions (ctl), after 5 and 20 min in the
presence of TBOA (10−4 M), with or without
ET (10−7 M), or after cell lysis (light grey bars)
induced by hypo-osmotic shock.
A–D. Means are from 27 determinations
(triplicate measurements in nine independent
experiments from three distinct cultures).
Statistical significance: *P < 0.05, **P < 0.01,
***P < 0.001, ns. Stars on a bar in a chart
denote that it differs from all the others.
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cultures, for either 5 or 20 min, [glutamate]e levels
increased substantially (see the ‘TBOA5’ and ‘TBOA20’
bars in Fig. 3D) compared with control values (‘ctl’ in
Fig. 3D). These data indicate that basal [glutamate]e is a
dynamic equilibrium maintained at a low level through the
uptake of glutamate by oligodendrocytes or/and
astrocytes. When the experiments were repeated using a
joint application of TBOA (10−4 M) and 10−7 M ET, for 5 or
20 min, [glutamate]e levels did not rise any higher than
when TBOA was applied alone. These experiments
suggest that the blockade of glutamate transporters prior to
ET application interferes with the effect of ET on
oligodendrocytes. Our data confirm the deduction men-
tioned earlier that ET-induced elevation of [glutamate]e
results from a primary effect on oligodendrocytes. This
does not however exclude the possibility that the increase
in [glutamate]e could be amplified by a secondary indirect
action on astrocytes, mediated by glutamate itself (i.e.
a glutamate-induced glutamate release mechanism,
Nedergaard et al., 2002).
ET does not cause oligodendrocyte lysis or death, and
does not form pores in their membrane
In addition to the change in glutamate membrane trans-
port (addressed earlier), the oligodendrocyte-dependent,
ET-induced increase in [glutamate]e may also result from
oligodendrocyte lysis/death. Whether 10−7 M ET was
applied for 5 or 20 min, no significant increase in the
enzymatic activity of glucose-6-phosphate hydrogenase
(a cytosolic enzyme) was detected in the extracellular
medium. Note that high levels of this enzymatic activity
were detected upon lysing the cells with osmotic shock
(Fig. 4A). We did not find any evidence of ET-induced cell
death. Indeed, following the incubation of culture contain-
ing oligodendrocytes with ET 10−7 M for durations of up to
24 h, the percentage of oligodendrocytes stained by
trypan blue remained very low and unchanged in com-
parison with control experiments performed without ET
(Fig. 4B). Note that after treatment with the fixative agent
para-formaldehyde (PFA) (4% for 1 h), almost all the
oligodendrocytes were stained by trypan blue. We can
therefore state that the increase in [glutamate]e is not due
to oligodendrocyte membrane lysis or to the death of
these cells.
ET does not form pores in their membrane
In principle, the oligodendrocyte-dependent ET-induced
increase in [glutamate]e could result from leakage of
glutamate because of the formation of ET pores in the
plasma membrane. Indeed, the small molecular weight
of glutamate (∼ 150 Da) is below the cut-off size
(∼ 2300 Da) determined for the intracellular side of ET
pores (Nestorovich et al., 2010). As we observed earlier
(Chassin et al., 2007; Lonchamp et al., 2010), ET pores
are manifested by a decrease in transmembrane electri-
cal resistance (Rm), the extent of which is proportional to
Fig. 4. ET does not induce membrane leakage, cell death or pore
formation.
A. G6PDH activity determined in the absence of ET (ctl, open bar),
5 (dark grey bars) and 20 min (black bars) after ET 10−7 M
application, or after cell lysis (light grey bars) induced by
hypo-osmotic shock. Means are from 27 determinations (triplicate
measurements in nine independent experiments from three distinct
cultures).
B. Relative fraction of oligodendrocytes stained by trypan blue (i.e.
dead cells) before (ctl), after ET 10−7 M application for 1, 3 or
24 h, or for 1 h after addition to the PFA fixative agent for 1h.%
determined from 566, 474, 557,500 and 616 cells from five Petri
dishes.
Ci. Average individual oligodendrocyte Rm determined before (open
circles) and after (black circle) application of ET (10−7 M). Paired
determinations, n = 18.
Cii. Same type of experiment, except that BaCl2 (10−4 M) was
present in the extracellular medium, before and after ET (10−7 M).
Paired determinations n = 14. Note that because of the high
increase in Rm following BaCl2 applications, each data point
presents a mean of four series of Rm determinations before and
after ET was applied (i.e. 13.3 ± 1.1 min after ET).
D. Average individual oligodendrocyte Rm determined before and
10 min after AmB application (16.5 10−6 M final). Paired
determinations, n = 7.
A–D. Statistical significance as in Figure 3.
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the number of open pores. Using the patch-clamp tech-
nique, we performed individual cell measurements of Rm
on mature oligodendrocytes (identified morphologically)
before and after ET application. Prior to ET application,
average oligodendrocyte Rm was 85.4 ± 18.7 MΩ (n = 18,
from 18 Petri dishes). This Rm value is close to that pre-
viously determined with rat oligodendrocytes in acute
slices (Gipson and Bordey, 2002). As ET leads to signifi-
cant increases in [glutamate]e levels within 5 min or
less (see earlier), Rm was determined in ET-treated
oligodendrocytes after an average of 6.7 ± 0.7 min (same
cells as in control). No significant change was found in Rm
(Rm(ctl) = 85.4 ± 18.7 and Rm(ET) = 104 ± 21 MΩ, n = 18;
paired t-test: P = 0.75; Fig. 4Ci), indicating that ET does
not form pores in oligodendrocytes.
To exclude any possibility whatsoever of an ET pore
forming in the oligodendrocyte plasma membrane, we
performed additional experiments designed to increase
Rm to such an extent that the formation of an ET pore could
be detected by a marked decrease in Rm. Oligodendrocyte
Rm is mostly determined by the presence of inwardly
rectifying potassium channels (Kir channels, reviewed in
Olsen and Sontheimer, 2008; Hibino et al., 2010), which
are selectively blocked by Ba2+ ions (100 μM, Hagiwara
et al., 1978; Gaillard and Bossu, 1995; Gipson and
Bordey, 2002). The addition of 100 μM BaCl2 prior to the
application of 10−7 M ET to cultures caused a very marked
(∼ 20 fold) increase in oligodendrocyte Rm (compare data
in Fig. 4Ci and Cii, drawn from different sets of experi-
ments). When individual Rm determined for the 4 min pre-
ceding ET application was compared with individual
Rm determined 13.3 ± 1.1 min after ET, no significant
change was detected (average of pooled data: Rm Ba( )2+ =
M1554 232± Ω , Rm Ba ET( )2 1527 287+ + = ± , n = 12; paired
t-test: P = 0.88, Fig. 4Cii), thereby confirming the findings
mentioned earlier. We also checked that the presence
of Ba2+ did not prevent ET binding to cultured
oligodendrocytes (data not shown). In the presence of
10−4 M Ba2+, the average resting membrane conductance
(Gm = 1/Rm) of individual oligodendrocytes was ∼ 650 pS,
compared with ∼ 10 000 pS without Ba2+. Therefore, the
opening of a single ET pore (∼ 500 pS, Petit et al., 2001;
Nestorovich et al., 2010) should have been shown by an
increase in Gm to 1150 pS (i.e. 650 pS added to 500 pS)
and a corresponding decrease in Rm by a factor of ∼ 1.75.
For each recorded cell, the careful examination of the
individual plots of Rm (as determined every min) against
time did not show any abrupt changes – even transitional
– with a factor of 1.5–2.0 (not illustrated). In three out of 12
oligodendrocytes, a very slow decrease was observed in
Rm (a kind of rundown, resulting in a lower Rm (by factor of
∼ 2) within 10–12 min (Fig. 4Cii). However, the very slow
kinetic of this decrease is inconsistent with that of an ET
pore opening, which occurs within a few milliseconds. The
absence of ET-induced changes in oligodendrocyte Rm
(Fig. 4Ci and Cii) therefore rules out any possibility
of ET causing any pore formation whatsoever in the
oligodendrocytes. We then carried out an additional
experiment to test whether an unrelated pore-forming
agent could create pores in the oligodendrocyte plasma
membrane. The pore-forming antibiotic amphotericin B
(AmB, reviewed by Cohen, 2010) was indeed seen to
affect Rm, with AmB (16.5 10−6 M) inducing a rapid (in
2.5–6.0 min) and marked decrease in oligodendrocyte Rm
(Fig. 4D).
ET induces intracellular [Ca2+] oscillations in
cultured oligodendrocytes
ET induces a [Ca2+]i increase in both renal cell lines and
cultured cerebellar granule cells (Chassin et al., 2007;
Lonchamp et al., 2010), but the relationship between
this increase and the pore-forming activity of the
toxin remains to be established. To determine whether
this ET effect occurs in oligodendrocytes, individual
cellular cytoplasmic changes in [Ca2+]i were monitored in
morphologically mature oligodendrocytes (1 cell moni-
tored per dish) pre-loaded with the Oregon Green 1,2-
bis(o-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid
(BAPTA-1) acetyloxymethyl (AM) calcium probe. For each
of the monitored cells, fluorescence intensity (F) was con-
tinuously recorded for at least 5 min before (F0) and 30 min
after ET application. No or very few spontaneous [Ca2+]i
oscillations were detected in untreated oligodendrocytes
(Fig. 5Ai). However, many intracellular Ca2+ signals were
induced following ET application (10−9 M in Fig. 5Aii;
10−7 M in Fig. 5Aiii). All changes in [Ca2+]i were determined
for each of the analysed cells (Table 1): mean ΔF/F0
(Fig. 5Bi), latency before the first Ca2+ signal (Fig. 5Bii),
and cumulative duration during which [Ca2+]i was above
baseline values (Fig. 5Biii). Following ET application,
average fluorescence intensity over 30 min became sig-
nificantly higher (P < 0.01) than that determined for control
experiments performed without ET (control: ΔF/F0(ctl) =
0.008 ± 0.006, n = 8, individual values are in Fig. 5Bi,
open circles; ET 10−7 M: ΔF/F0(ET) = 0.205 ± 0.037, n = 34,
see individual values in Fig. 5Bi, black circles; see also
Table 1). We also noticed that a fraction (8 of 34;
i.e. ∼ 24%) of the recorded oligodendrocytes did not show
any response to ET via significant change in [Ca2+]i within
the 40 min following ET application. As the proportion of
responding oligodendrocytes (76%) is similar to that
observed in ET-labelled oligodendrocytes (79%, see
Fig. 2), the non-responding cells (∼24%) may correspond
to oligodendrocytes that do not express the ET receptor
(∼21%). In responding oligodendrocytes, the latency
between ET application and the first [Ca2+]i oscillation
observed was on average 12.8 ± 1.8 min (Fig. 5Bii). The
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period of time during which [Ca2+]i was higher than basal
values varied significantly from cell to cell (Fig. 5Biii).
The ET-induced [Ca2+]i oscillations were comprised of
different types of Ca2+-events (Fig. 5A), which could be
sorted into four categories (see pie chart in Fig. 5Ci)
including peaks of small (28%) or large (30%) amplitude,
bursts of overlapping peaks (39%), and rare plateau
events during which [Ca2+]i levels remained high for
minutes before subsiding (3%). By their time of onset
(Fig. 5Cii) and duration (Fig. 5Ciii), the three former types
of Ca2+ events (total = 97%) appeared to belong to the
same class.
ET-induced [Ca2+]i oscillations are due to the stimulation
of metabotropic glutamate receptors
The short-living, ET-induced intracellular Ca2+ events
described earlier are highly reminiscent of the [Ca2+]i
oscillations produced by neurotransmitter application to
oligodendrocytes and/or Ca2+ release from intracellular
Ca2+ stores in glial cells (Charles et al., 1991; Cornell-Bell
and Finkbeiner, 1991; Verkhratsky and Kettenmann,
1996; Butt, 2006; Luyt et al., 2006; Nedergaard et al.,
2010). We examined whether the ET-induced [Ca2+]i
oscillations depended on the presence of extracellular
Ca2+. About 5 min prior to ET application, the control
extracellular medium was replaced by a modified
milieu containing 4 mM MgCl2 and 0 mM CaCl2. When
ET 10−7 M was added, no Ca2+ event was observed
and the average change in fluorescence was not
distinct from control experiments performed without ET
( ΔF F ET Ca20 0 0 01 0 02( ) . .+ = ± , ns, n = 8). As intracellular
Ca2+ stores in many cell types can be quickly ex-
hausted when extracellular Ca2+ is removed, we tested
this possibility. In the absence of extracellular Ca2+,
10 mM final application of caffeine (a drug that recruits
Fig. 5. ET induces intracellular [Ca2+]i rise in oligodendrocytes. Changes in [Ca2+]i were monitored by determining the relative changes in
fluorescence (ΔF/F0) of cells loaded by the Oregon green probe.
A. Typical examples of ΔF/F0, plotted against time (min) in an oligodendrocyte in the absence (control) or after application (arrow) of ET
(10−9 M, Aii; 10−7 M Aiii). Note the [Ca2+]i oscillations appearing after ET application.
B. Quantification of the Ca2+ signals induced by ET. Each data point corresponds to the analysis of a cell recorded in one culture dish. Bi.
Average ΔF/F0 determined over 30 min, in the absence of ET (control condition, open circles, n = 8) or starting after 10−7 M ET application
(filled circles). n = 34, two asterisks denote P < 0.01. Note that 26 of the 34 cells did not respond to ET by a significant increase in ΔF/F0. Bii.
Latency (min) before appearance of the first ET-induced Ca2+ signals (determined from the 23 responding cells). Biii. Cumulative time during
which ΔF/F0 was over baseline values for the first 30 min after ET application (determined from 18 responding cells displaying no rundown of
ΔF/F0 before ET application).
C. Characteristics of the individual ET-induced Ca2+ signals, sorted according to their kinetics and amplitude: peaks of small (a, black) or large
(b, dark grey) amplitude, bursts of overlapping peaks (c, light grey), and plateau events (d, white). Ci. Pie chart representing their relative
proportions (%). Cii. Their respective times of onset, and, Ciii, duration.
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Ca2+ reticular stores by activating the ryanodin receptors,
RyR) failed to induce any increase in [Ca2+]I [ΔF/
F0(Caffeine 0 Ca2+) = 0.01 ± 0.01, n = 8, not significant (ns) ],
whereas an increase was observed in the presence
of extracellular Ca2+-containing medium (ΔF/F0(Caffeine) =
0.17 ± 0.04, P < 0.001, n = 9). The loss of ET effect in the
absence of extracellular Ca2+ might therefore be due to
the exhaustion of intracellular Ca2+ stores, and/or a lack
of Ca2+ influx through channels conducting store-
operated Ca2+ entry or ligand-gated channels, with the
exception of the voltage-dependent Ca2+-channels that
are not expressed by mature oligodendrocytes (reviewed
by Verkhratsky and Kettenmann, 1996; Butt, 2006;
Nedergaard et al., 2010). Thapsigargin (10−6 M) was
applied to cultures for 30 min in order to exhaust
endoplasmic reticulum (ER) Ca2+ stores by blocking the
SERCA (Sarco/ER Ca2+ ATPase) pump. Following this
pretreatment, which induced a moderate stable increase
in basal [Ca2+]I (data not shown), ET (10−7 M) did not
induce Ca2+ signals (an example of 30 min continuous
recording is provided in Fig. 6Ai). Data are summarized in
Fig. 6Aiv, and Table 1. To determine whether the Ca2+
signals were induced by activation of the RyR and/or
IP3-receptors (IP3-R), cultures were pretreated for 30 min
with Dantrolene (10−5 M) a specific blocker of the various
RyR subtypes, or 2-aminoethoxydiphenylborane (2-APB,
10−4 M), a pharmacological agent that inhibits the various
IP3-R subtypes, but also most of the channels mediating
store-operated Ca2+ entry, such as TRP and Orai chan-
nels (reviewed by Harteneck and Gollasch, 2011). ET was
unable to induce Ca2+ signals after pre-incubation of cul-
tures with 2-APB (Fig. 6Aii and Aiv), while Ca2+ signals
were detected after treatment with dantrolene (Fig. 6Aiii
and Aiv). A summary of data is displayed in Table 1. As
oligodendrocytes can express TRPC3 (Fusco et al.,
2004) and rare Orai channels (Verkhratsky and Parpura,
2014), ET-induced Ca2+-signals may be due to the mobi-
lization of Ca2+ from the ER (because of the activation of
IP3-R, but not RyR) and/or store-operated Ca2+ entry.
Further pharmacological investigation, including the pos-
sible upstream activation of phospholipase C, which
catalyses IP3 production, was found to be impossible due
to the deleterious effect of the necessary drugs on
oligodendrocytes.
As ET-induced increase in [glutamate]e reaches near
completion in ∼ 5 min (Fig. 3), yet the ET-induced Ca2+
intracellular events occurred later (after a delay of
∼ 13 min, Fig. 5), therefore we next investigated the
possibility that the latter were a consequence of the
former. Indeed, the activation of glutamate receptors is
one of the main events inducing Ca2+ signalling in mature
oligodendrocytes, in response to either the activation
of Ca2+-permeable glutamate receptors (such as the
N-methyl-D-aspartate receptor, also known as NMDA-R,Ta
b
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Fig. 6. Pharmacological dissection of ET-induced Ca2+ signalling pathway.
A. Typical examples of ΔF/F0 plotted against time in cultured oligodendrocytes in the presence of a pharmacological agent either alone (top
recordings) or with ET (bottom recordings). The arrow denotes ET application time. Identical scale bars for all traces. Effects of treating
cultures (in the absence or presence of 10−7 M ET) with: (Ai) the SERCA pump blocker thapsigargin (0.5 10−6 M), (Aii) the IP3-R and
store-operated Ca2+ entry antagonist 2-APB (10−4 M), or (Aiii) the RyR antagonist Dantrolene (10−5 M). Aiv. Summary of the pharmacological
data. Mean ΔF/F0 determined over 30 min in the presence of the mentioned pharmacological agents, with (+) or without (−) of ET (10−7 M).
B. Glutamate-induced [Ca2+]i rise in oligodendrocytes. Bi. Typical examples of changes in ΔF/F0 plotted against time and induced in
oligodendrocytes by application of glutamate (10−5 M: top recording, or 10−6 M, bottom recording). Bii–Biv. Summary of the corresponding data
(open squares: 10−6 M glutamate; filled squares: 10−5 M). Bii. Mean ΔF/F0 determined over 30 min in the presence of glutamate; Biii. Latency
between glutamate application and first Ca2+ signal. Biv. Cumulative time during which ΔF/F0 was over baseline values, as determined over the
first 30 min after glutamate application.
C. ET-induced [Ca2+]i rise in oligodendrocytes was due to activation of glutamate metabotropic receptors. Ci. Typical changes in ΔF/F0 against
time in cells pretreated with the mGluR1 specific antagonist JNJ16259685 (2 10−6 M), with or without the presence of ET (10−7 M). Cii. Same type
of experiment, with prior treatment of cells with NMDA–R-specific antagonist, D-APV (5 10−5 M). Scale bars identical to those in A. Ciii.
Identical to Aiv.
A–C: **P < 0.01, ns.
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or the α-amino-3-hydroxy-5-methylisoxazole-4-propionic
acid receptor, also termed AMPA-R) or the G-protein
coupled glutamate metabotropic receptors (mGluR)
from group I (mGluR1 and mGluR5), which activate
phospholipase C and the ensuing production of IP3
(reviewed in Butt, 2006). L-glutamate application to cul-
tures (10−6 M or 10−5 M, Fig. 6B) induced Ca2+ signals in
oligodendrocytes that were very similar to those induced
by ET (Figs 5A and 6B). As the selective agonists of
AMPA-R ((s)-AMPA) and mGlurR5 [(RS)-2-chloro-5-
hydroxyphenylglycine] failed to induce Ca2+-signalling
(data not shown), it is likely that AMPA-R and mGluR5 are
not expressed by oligodendrocytes under our culture con-
ditions. These data are fully consistent with the down-
regulation of AMPA-R (Alberdi et al., 2005; De Biase
et al., 2010) and mGluR5 (Luyt et al., 2006) occurring
when oligodendrocyte precursor cells differentiate into
oligodendrocytes, in culture, and the progressive loss of
Ca2+ oscillations induced by mGluR5 agonists (Luyt et al.,
2006). Importantly, incubation with JNJ16259685 (2 10−6 M),
a highly potent and selective mGluR1 antagonist
(Lavreysen et al., 2004), completely prevented the induc-
tion of Ca2+ events by ET 10−7 M (Fig. 6Ci and Ciii). While
incubation with D-(-)-2-amino-5-phosphonovaleric acid
(D-APV, 5 10−5 M), a specific blocker of NMDA-R, did not
prevent the ET-induced Ca2+ oscillations (Fig. 6Cii and
Ciii), it did cause a significant increased latency for the
first ET-induced Ca2+-signal (Table 1) and result in a lower
cumulative Ca2+ rise (Table 1). Note that none of the drugs
mentioned induced Ca2+ signals when used alone (see
the control ΔF/F0 recordings in Fig. 6A and C). These
results indicate that the activation of NMDA-R, which may
mediate influx of Ca2+ from extracellular medium, is not
responsible for the observed Ca2+ events induced by ET.
ET induces demyelination of Purkinje cells axons in the
cerebellar granular layer
Oligodendrocytes are very sensitive to glutamate and
Ca2+ signalling, which can lead to demyelination. Indeed,
the binding of Ca2+ to calmodulin can not only cause the
dissociation of MBP from actin and MBP from the mem-
brane, but also dissociates the microtubules from MBP,
thereby altering the myelin (reviewed in Harauz and
Boggs, 2013). Excessive glutamate/Ca2+ signalling may
also cause oligodendrocyte death and associated
demyelination (reviewed in Matute et al., 2006; Bakiri
et al., 2009; Matute, 2011). As ET induces [glutamate]e
elevation and thus [Ca2+]i oscillations, we investigated in
vitro the possibility that ET may induce myelin alteration.
To achieve this, organotypic cultures of P10–P11 rat cer-
ebellar slices were prepared. After a 6-day period to allow
myelination of Purkinje cells axons to develop in vitro, the
slices were maintained for 24 h in a medium containing no
toxin (control slices) or ET, then fixed. In the ‘control’
slices, numerous Purkinje cell (28 kD+ cells) axons cross-
ing the granular layer were delineated by a MBP+ signal
denoting the axons surrounded by myelin (Fig. 7A and B).
When slices were incubated with ET (10−7 M), the MBP+
immunosignal was strongly diminished and the MBP+
structures were dramatically disorganized, while the
28 kD+ immunosignal and Purkinje cells structures
remained similar to those observed in ‘control’ slices
(Fig. 7C and D). Similar results, albeit less dramatic, were
obtained using 10−9 M ET (data not shown). The effect of
10−7 M ET on myelination was quantified by counting
MBP+ and 28 kD+ pixels from region of interest (ROI)
selected from the upper region of the granular layer
directly below the Purkinje cell layer (Fig. 7E). While the
fraction (%) of 28 kD+ pixels in ROI was similar in the
control condition and after ET (130 and 130 ROI analysed,
P = ns; Fig. 7Ei), the fraction (%) of MBP+ pixels
decreased dramatically after ET in comparison with
control conditions (P < 0.001, Fig. 7Eii). Consistently, the
fraction of MBP+ among 28 kD+ pixels also decreased
significantly (P < 0.001, Fig. 7Eiii). These collective data
indicate that ET induces marked demyelination of Purkinje
cells axons, without damaging the Purkinje cells and their
axons.
Demyelination is induced by an ET-induced rise
in [glutamate]e
To determine whether the ET-induced demyelination is
causally linked to a [glutamate]e increase, as we observed
in the primary cell cultures, the organotypic slices were
incubated with ET (10−7 M) in the presence of JNJ16259685
(2 10−6 M) and D-APV (5 10−5 M) to prevent the activation
of both mGluR1 and NMDA-R respectively. Under this
pharmacological condition, ET 10−7 M failed to induce sig-
nificant demyelination (Fig. 8A and B). Note in Figure 8
the presence of numerous Purkinje cell axons in the
granular cell layer (28 kD+) surrounded by myelin (MBP+)
in the JNJ16259685, D-APV, ET-treated slices. The result of
the pixel analysis in ROI is presented in Fig. 8C. These
data indicate that the demyelination caused by ET in
cultured rat cerebellar slices is triggered by an initial
[glutamate]e increase caused by ET.
Discussion
ET binds to myelin and oligodendrocytes and acts
on them
The binding of ET to rat brain white matter and rat
oligodendrocytes in primary culture is fully consistent with
previous studies performed with other animal species
(see Introduction, and Soler-Jover et al., 2007;
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Fig. 7. ET-induced demyelination of Purkinje cell axons in organotypic culture of cerebellar slices. GCL, granule cells layer; PCL, Purkinje
cells layer; ML, molecular layer.
A and C. Immunostaining of (i) the 28 kD protein (green, to label Purkinje cells), and (ii) MBP (red, to label myelin) in cerebellar slices
maintained in organotypic cultures, treated without (A) or with (C) ET 10−7 M for 24 h. iii, their merged image. Scale bar = 25 μm.
B and D. Same presentation, except that magnifications of the regions denoted by a dotted frame in A and C are shown. Scale bar = 12.5 μm.
E. Quantification of the immunostaining of 28 kD and MBP determined from analysing ROI of 100 × 100 pixels selected in the granular layer.
White-filled box plots are for slices that were not treated with ET (n = 92 ROI); black-filled box plots are for the ET-treated slices (n = 116 ROI).
Horizontal lines denote medians (in red), and the means (in green). Ei. % of 28 kD+ pixels in ROI. Eii. % of MBP+ pixels in ROI. Eiii. % of
28 kD+ and MBP+ pixels. ***P < 0.001.
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Dorca-Arévalo et al., 2008; Lonchamp et al., 2010). As
ET-induced [glutamate]e increase (the primary action of
ET on oligodendrocytes, as discussed later) can be neu-
tralized by specific anti-ET antibodies, the various mani-
festations we describe here (i.e. initial rise in [glutamate]e
and ensuing [Ca2+]i oscillations and demyelination) are
therefore the consequences of the specific binding of ET
to the oligodendrocytes (Fig. 9, step 1). As this toxin
binding and the consequent manifestations are detected
using 10−9 M ET, oligodendrocytes probably express
high-affinity ET receptor(s). In primary cultures, some
oligodendrocytes are not targeted by ET (∼ 20% using
10−7M ET), while some others do not respond to ET by
initiating intracellular Ca2+ events. Thus, ET-receptor is
expressed in a subset (∼ 80%) of oligodendrocytes and all
the observed ET effects are primarily induced by ET
action on these cells.
ET does not form pores in oligodendrocytes
ET forms pores that are characterized by a very high
conductance (∼ 500 pS) (Petit et al., 2001; Nestorovich
et al., 2010). Therefore, the presence of just one pore can
cause a marked decrease in Rm. The pore-forming activity
of ET is confirmed in certain cell types, as denoted by a
marked ET-induced decrease in Rm within renal collecting
duct mpkCCDcl4 cells and neurons (Chassin et al., 2007;
Lonchamp et al., 2010). It is crucial to note that while ET
induces several cell effects (i.e. [glutamate]e rise and
intracellular [Ca2+]-oscillations) at low concentrations
(10−9 M), high concentrations (10−7 M) do not induce any
decrease in Rm, even under conditions permitting the
detection of a single ET pore (for more details, see Ba2+
experiments). ET therefore acts on oligodendrocytes
without forming pores. This is supported by evidence that
Fig. 8. Blocking mGluR1 and NMDA-R prevents ET-induced demyelination.
A, B. Same presentation as in Fig. 7C,D, except that ET 10−7 M was applied to the cerebellar slices in organotypic culture for 24 h in a culture
medium containing specific antagonists of the NMDA-R (D-APV, 5 10−5 M) and mGluR1 (JNJ16259685, 2 10−6 M).
C. The corresponding quantifications (same presentation as in Fig. 7E), after treating the slices without (white box plots, n = 100 ROI) or with
(black box plots, n = 100 ROI) ET 10−7 M with D-APV and JNJ16259685 for 24 h.
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despite the capacity of ET pores to accommodate a
transmembrane flux of soluble small molecules of up to
∼ 2300 Da from the intracellular side (Nestorovich et al.,
2010), there is no leakage of the Ca2+-fluorescent probe
Oregon Green BAPTA-1 (MW ∼ 500 Da), the basal fluo-
rescence of which remains stable over the whole duration
of the experiments (Figs 5 and 6). Our study is the first to
provide compelling evidence that ET can act on target
cells without creating pores, and shows that ET binding to
specific receptors (Fig. 9, step 1) activates pathway(s)
that mediate the manifestations induced by the toxin.
An increase in [glutamate]e results from direct primary
action of ET on oligodendrocytes
The collective evidence provided in this paper fully
supports the possibility that a direct action of ET on
oligodendrocytes causes rapid [glutamate]e elevation
(Fig. 9, step 3). This raises the question of the possible
mechanisms involved. Although glutamate is small
enough (∼ 150 Da) to pass through ET pore lumen and
certain other types of membrane channels (Nedergaard
et al., 2002), the lack of any ET-induced change in Rm
rules out this possibility. Glutamate leakage because of
oligodendrocyte plasma membrane severing is also
unlikely. Indeed, despite the fact that about 80% of these
cells respond to ET (see the [Ca2+]I oscillations), none of
them die (no staining of oligodendrocytes by trypan blue
up to 24 h after 10−7 M ET application) or show any
evidence of plasma membrane rupture (the cytosolic
enzyme glucose-6-phosphate hydrogenase is not
detected in the extracellular compartment). It is also
unlikely that the increase in ET-induced [glutamate]e
results from glutamate exocytosis, a minor process in glial
cells that is still under debate (Nedergaard et al., 2002;
Hamilton and Attwell, 2010) and has not been described
in oligodendrocytes to date. The most likely explanation is
that ET acts on glutamate membrane transport (Fig. 9,
step 2). Indeed, oligodendrocytes are key actors in
the regulation of extracellular glutamate homeostasis
(DeSilva et al., 2009). They express three excitatory
amino acid transporters for glutamate (Domercq and
Matute, 1999; Danbolt, 2001; Pitt et al., 2003; DeSilva
et al., 2009), which are all blocked by TBOA (Shimamoto
et al., 1998). In accordance with this notion, TBOA pro-
duced a high [glutamate]e increase in the primary cultures
in the absence of ET. It is likely that the release and
uptake of glutamate by both the oligodendrocytes and
astrocytes in the primary culture are balanced in order to
maintain a low basal level of extracellular glutamate. This
means that an ET-induced alteration of this dynamic equi-
librium may cause the observed increase in [glutamate]e
by either increasing the release or inhibiting the uptake of
glutamate. Our data do not permit us to discern between
Fig. 9. Schematic representation of the
cascade of ET effects in oligodendrocytes.
Following its binding to high-affinity
receptor(s) (step 1), ET activates an as yet
unidentified pathway, causing alteration in
membrane glutamate transport (step 2). The
resulting increase in [glutamate]e (step 3)
induces autocrine activation of mGluR-1 (step
4), possibly benefiting from synergistic
activation of NMDA-R. This is followed (step
5) by production of IP3, the activation of IP3-R,
Ca2+ release from ER and possibly
store-operated channel (SOC)-mediated
Ca2+-entry, causing [Ca2+]i oscillations (step 6).
This triggers demyelination (step 7).
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these two opposite possibilities. Indeed, if ET favours the
release of glutamate, the lack of further ET-induced
glutamate increase after TBOA may result from glutamate
depletion of TBOA-treated oligodendrocytes. Conversely,
if ET inhibits glutamate uptake, such an effect cannot
occur after prior inhibition of the transporter by TBOA. The
primary cultures contained oligodendrocytes, but also a
noticeable population of astrocytes. As these two cell
types can release glutamate in response to a [glutamate]e
increase (Nedergaard et al., 2002), it is possible that the
[glutamate]e that we observed after ET treatment is the
result of ET primary direct action on the oligodendrocytes,
amplified by a glutamate-induced glutamate release by
astrocytes. An important issue for future investigations is
the deciphering of the signalling pathway linking ET
binding to the changes in glutamate membrane transport
(Fig. 9, step 2).
Intracellular [Ca2+] oscillations and demyelination are
indirect effects of ET, and result from the initial
toxin-induced rise in [glutamate]e
ET induces [Ca2+]i oscillations in oligodendrocytes, which
then cease upon the removal of extracellular Ca2+, the
blocking of the SERCA pump, or the addition of 2-APB
(which blocks the IP3-Rs and store-operated Ca2+ entry).
However, these oscillations remain almost unaffected fol-
lowing the blockade of RyR. This is in line with current
knowledge on Ca2+-signalling in glial cells (Verkhratsky
and Kettenmann, 1996; Butt, 2006; Nedergaard et al.,
2010), and suggests that these ET-induced [Ca2+]i oscil-
lations may be primarily initiated by the release of Ca2+
into the cytosol from ER stores following the activation of
the IP3 pathway, and may implicate store-operated
Ca2+ entry (Fig. 9, step 5). ET-induced Ca2+ signals in
oligodendrocytes are prevented by specifically antagoniz-
ing mGluR1 with JNJ16259685. Thus, the [Ca2+]i oscillations
(Fig. 9, step 6) are caused by activation of the mGluR1
(Fig. 9, step 4) in response to the [glutamate]e rise (Fig. 9,
step 3) induced by the toxin. This accords with the view
that glutamate induces calcium oscillations in glial cells
(Charles et al., 1991; Cornell-Bell and Finkbeiner, 1991)
and the mGluR – phospholipase C – IP3-R pathway is a
prominent one in oligodendrocytes (Luyt et al., 2003;
2006). The [glutamate]e measured after ET application is
high enough (1–1.5 10−6 M, with higher values in the vicin-
ity of the cells) to substantially activate mGluR1 (Conn
and Pin, 1997), and also other types of glutamate recep-
tors like the NMDA-R. Consistent with the earlier, we
found that the activation of NMDA-R is synergistic with
that of mGluR1 in order to induce [Ca2+]i oscillations, as
suggested by delayed Ca2+ events when NMDA-R
is blocked by D-APV. The prominent ET-induced
demyelination (Fig. 9, step 7) in cultured slices is also a
secondary effect caused by the toxin-induced [glutamate]e
increase. Indeed, ET-induced demyelination is prevented
by mGluR1 and NMDA-R antagonists (Fig. 9, step 4).
Overall, these data are fully consistent with the notion
that oligodendrocytes are highly vulnerable to glutamate-
dependent excitotoxic insults (reviewed in Matute et al.,
2006; Matute, 2011), and that a [glutamate]e increase
causes myelin alterations (Smith et al., 2000; Matute
et al., 2001; Kostic et al., 2013).
As demyelination is not a primary action of ET,
but rather an indirect consequence of toxin-induced
oligodendrocyte-dependent elevation of [glutamate]e, it is
possible that cells (neurons, astrocytes or microglia) that
are not directly targeted by ET may contribute to the
amplification of ET action on oligodendrocytes. For
instance, glutamate-induced glutamate release by
astrocytes (discussed earlier) may allow [glutamate]e to
reach sufficiently high levels to activate Ca2+ signalling
and demyelination. Such synergistic action between
oligodendrocytes and astrocytes accords with the notion
that glutamate release by astrocytes may cause
demyelination (Matute et al., 2006; Matute, 2011).
An important point is that the demyelination process
does not necessarily involve the death of the oligo-
dendrocytes. Indeed, elevated [Ca2+]i can trigger myelin
alteration by remodelling the intracellular cytoskeleton
(reviewed in Harauz and Boggs, 2013). Therefore, con-
sistent with our observation that ET does not kill
oligodendrocytes (see the trypan blue experiments), it is
likely that the glutamate-induced [Ca2+]i oscillations signal
the demyelination process. Note also that the changes in
[Ca2+]i consist of repeated brief oscillations that prevent
[Ca2+]I from building up and probably keep levels below
the threshold for apoptosis or necrosis.
Does ET cause demyelination in vivo?
Damage to white matter has been reported in cases of
C. perfringens B or D enterotoxaemia in ruminants
(Buxton and Morgan, 1976; Finnie, 1984a,b; Uzal and
Kelly, 1997; Uzal et al., 1997). However, it remains
unclear whether they are caused by oedemas or
ET-induced demyelination. Indeed, no demyelination has
been described in these studies. It is possible that the
death caused by this disease occurs too quickly to induce
any noticeable demyelination. Although humans are not
usual targets for ET, a study published a short time ago
reported the increased frequency of ET immunoreactivity
in the sera and cerebrospinal fluid of patients suffering
from multiple sclerosis (Rumah et al., 2013) – a white
matter disease caused by demyelination.
To conclude, this study reveals that ET, a bacterial toxin
previously reported as damaging its cell targets via the
formation of pores, can act at low concentrations (10−9 M)
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on certain cells without forming pores. In oligoden-
drocytes, the different cell manifestations are organized
into a cascade of effects (summarized in Fig. 9) initiated
by ET binding to its receptor. As ET induces demyelination
in vitro, this toxin can be considered as a causal candi-
date, among others, in the initial events of certain myelin
pathologies.
Experimental procedures
Ethics statement
All experimental procedures are in accordance with European
and French guidelines for animal experimentation and have been
approved by the Bas-Rhin veterinary office, Strasbourg, France
(authorization number 67-26 to BP) and by the Paris veterinary
office, France (authorization number 75–279 to MP).
Rat cerebellar slices
P20-P30 Wistar rats (Animal facility of CNRS-Strasbourg Univer-
sity, UMS3415 Chronobiotron) were decapitated after isoflurane
general anaesthesia. Acute slices (150 μm thick) were prepared
from rat cerebellum following the protocol described by
Lonchamp et al. (2010), but using a Microm HM650V slicer
(Thermo Scientific). Slices were maintained in ice-cold artificial
cerebrospinal fluid (ACSF) bubbled with carbogen (95% O2 and
5% CO2) (Lonchamp et al., 2010).
Cerebellar primary cultures containing oligodendrocytes
and astrocytes
Primary cultures of newborn (P0–P1) Wistar rat cerebellum
(Animal facility of CNRS-Strasbourg University, UMS3415
Chronobiotron) were prepared as detailed by Gaillard and Bossu
(1995) and Boussouf et al. (1997). In essence, the culture con-
ditions were designed in order to select cell types of interest while
eliminating certain others. To allow the growth of glial progenitors
while preventing the survival of neurons, freshly dissociated cer-
ebellar cells were re-suspended in Dulbecco/Vogt modified
Eagle’s minimal essential medium (DMEM) supplemented with
high glucose as described by Gaillard and Bossu (1995) and
Boussouf et al. (1997) and containing 5% decomplemented
horse serum and 5% decomplemented foetal calf serum. When
cultured in this medium for 6 days (with a change of medium
every 2 days), cells were comprised of progenitor glial cells and
astrocytes, but no oligodendrocytes (Boussouf et al., 1997). To
obtain cultures containing a maximum number of oligoden-
drocytes, but the lowest possible amount of astrocytes, the cells
were rinsed after 2 days of culture in the aforementioned medium
and exposed to a serum-free, chemically defined medium con-
sisting of DMEM supplemented with high glucose, as previously
described (Gaillard and Bossu, 1995; Boussouf et al., 1997).
Experiments based on oligodendrocytes were performed at least
4 days after transfer to this second stage of culture. As some
Petri dishes could contain some residual granule cells, the culture
dishes were checked under the microscope prior to any experi-
ment, and were eliminated if contaminated by more than 1.5% of
granule cells.
Organotypic culture of cerebellar slices
P10–P11 Wistar rats were anaesthetized by inhalation of
isoflurane before decapitation. According to established
methods (Stoppini et al., 1991), cerebella were dissected out
into cold (4°C) minimum essential medium (MEM, Fisher).
Parasagittal slices (300 μm thick) were made using a McIlwain
tissue chopper (Mickle) and separated gently in cold MEM. The
slices were then transferred onto Milicell cell culture inserts
(Millipore), placed in six-well plates, containing 1 ml of culture
medium composed of 50% MEM, 25% basal medium eagle
(Fisher), 25% heat-inactivated horse serum, and supplemented
with 2 10−3 M GlutaMAXTM (Fisher), 50 UI ml−1 penicillin,
50 μg ml−1 streptomycin and 4 g l−1 glucose. The cultures were
incubated at 37°C in a humidified incubator equilibrated with
95% air/5% CO2. Slices were cultured for 6 days to allow the
myelination of Purkinje cells. The medium was completely
changed every 2 days.
ET materials and neutralization
ET was purified from an overnight culture of C. perfringens type
D strain NCTC2062, as previously described (Petit et al., 1997).
The purity of ET (> 90%) was checked using sodium dodecyl
sulfate polyacrylamide gel electrophoresis. Aliquots of ET were
stored at −80°C. Specific anti-ET antibodies were raised in
rabbits by subcutaneous injections of formalin-treated wild-type
ET then immunopurified using wild-type ET bound to CNBr-
activated Sepharose 4B column (GE Health Care). The neutral-
izing activity of the anti-ET antibodies was assessed in
Madin-Darby canine kidney (MDCK) cells. Serial dilutions of
anti-ET antibodies were mixed with fixed concentrations of ET for
30 min at RT then applied to MDCK cell monolayers grown on
96-well plates. Cell viability was monitored using the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide tetrazolium
reduction (MTT) assay, as described by Petit et al. (2001) 3 h
after incubation at 37°C. Using 10−9 M ET, a complete neutrali-
zation was obtained with 10−9 M-specific anti-ET antibodies,
whereas when 10−8 ET was used, a 10-fold increase in anti-ET
antibodies (10−7 M) versus ET was required for a complete
neutralization.
Extracellular working solutions
Overall, experiments on primary cultures were performed
using an external working solution containing (in 10−3 M):
140 NaCl, 5.4 KCl, 0.4 KH2PO4, 1 CaCl2, 1 MgCl2, 0.8 MgSO4,
5 D+-galactose, 10 glucose and 20 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), adjusted at 7.4 with
NaOH (Gaillard and Bossu, 1995). For electrophysiological
recordings, the working medium was modified by a solution con-
taining (in 10−3 M): 145 NaCl, 5.4 KCl, 2 CaCl2, 2 MgCl2, 10
HEPES/Tris, 10 glucose and 10 sucrose. The pH was adjusted to
7.4 with TrisOH. When needed, 10−4 M BaCl2 was added to the
working external medium prior to recordings. Experiments on
acute and organotypic slices were performed using the ACSF as
working medium. To avoid non-specific adsorption of ET, all of the
mediums were supplemented with bovine serum albumin (BSA,
2%). ET and/or various pharmacological agents were diluted in
this medium at the desired concentrations.
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ET detection and the immunochemistry of
specific markers
Cerebellar acute slices, organotypic slices and cerebellar primary
cultures were pre-incubated with BSA (2%, in working solution)
before being submitted to ET (at the concentration indicated, for
10 min, at RT). They were then fixed using paraformaldehyde 4%
in phosphate buffer solution (PBS) at RT (30 min), followed by
transfer to a cold (4°C) saturation solution containing PBS with
0.2% Triton (to allow permeabilization), 2% BSA and 10% normal
goat serum (Millipore), overnight. To reveal ET bound to its target
cells, the primary anti-toxin antibodies (see earlier) were applied
overnight (dilution 1/500) at 4°C or 2 h at RT under agitation.
Secondary anti-rabbit antibodies tagged with Alexa 488 (Molecu-
lar Probes) were applied overnight at 4°C or 2 h at RT under
agitation. To identify the ET-targeted cells in slices or in cultures,
a similar protocol to the one detailed earlier was used, except that
immunolabelling of ET and the cell markers of interest were run
simultaneously (overnight at 4°C, or 2 h at RT under agitation),
followed by three washes in the saturation solution and an over-
night application of secondary antibodies (or 2 h at RT under
agitation). Specific antibodies against the following markers were
used: MBP (anti-MBP, ABD Serotec, rat monoclonal, 1/500),
GFAP (anti-GFAP, Sigma-Aldrich, mouse monoclonal diluted
1/400), Iba-1 (Wako, rabbit polyclonal, 1/300) and 28 kD protein
(also known as Calbindin, Sigma-Aldrich, mouse monoclonal,
1/1500). Finally, fixed slices or cut out 35 mm dishes containing
primary cultures were mounted on glass coverslips with Prolong®
Gold antifade reagent (Molecular Probes). Confocal images were
produced at the In vitro Imaging Facility of the Neuropôle/Centre
de Neurochimie de Strasbourg (France), using a Leica SP5II
inverted confocal microscope (10×; 20× or 63× objectives).
Fields of 1024 × 1024 pixels were acquired using 405 nm diode
(ultraviolet), 488 nm argon laser (green), and 561 nm Diode-
pumped solid-state laser (red).
Electrophysiological determination of passive plasma
membrane resistance in cultured oligodendrocytes
Whole-cell membrane recordings were made using 5 MΩ
microelectrode and the patch-clamp technique, as detailed by
Lonchamp et al. (2010). Oligodendrocytes were identified on
the basis of their typical morphology (40× objective, differential
interference contrast (DIC) mode). Only cells presenting a
resting transmembrane potential below −40 mV were used.
Transmembrane potential was held at −60 mV, then passive
transmembrane resistance (Rm) was determined at RT from the
current changes (ΔI) induced by a series of hyperpolarizing and
depolarizing square pulses (ΔV, 200 ms duration, increasing by
4 mV steps), under voltage-clamp. This protocol was repeated
once a minute for the whole duration of the experiment. For each
set of data (i.e. a protocol), Rm was determined by averaging the
ΔV/ΔI values, or from linear fitting of ΔI = f(ΔV) plots.
Glutamate assay
Determination of extracellular concentration of glutamate was
determined as described in Lonchamp et al., 2010; Jover et al.,
2013 using the Amplex™ Red Glutamic Acid/Glutamate Oxidase
Assay Kit (Molecular Probes), except that cells were cultured on
35 mm culture dishes. The calibration for each experiment was
performed from a standard curve established using samples of
the working solution containing known concentrations of
glutamate. The determination of the maximal possible external
concentration of glutamate was determined by lysing the cells
with a hypo-osmotic shock (distilled water containing 10−2 M
Tris-HCl, pH 7.4). The basal concentration (i.e. control) was
measured by incubating the cells with the working medium
without ET.
Glucose-6-phosphate dehydrogenase (G6PDH) assay
The extracellular activity of G6PDH was measured as described
(Batchelor and Zhou, 2004; Jover et al., 2013). In essence, the
experimental protocol was similar to that used for the glutamate
assay except for the 50 μl reagent, which contained 2
10−3 M glucose-6-phosphate, 1.5 10−5 M resazurin, 0.5 10−3 M
nicotinamide adenine dinucleotide phosphate (NADP) and
0.5 U ml−1 diaphorase. Activity of the G6PDH after ET application
or cell lysis was normalized to that determined under control
condition.
Test of cell viability
A trypan blue exclusion test of cell viability was carried out in
order to detect oligodendrocyte death or survival after the expo-
sure of cultures to ET (10−7 M) for 1, 3 or 24 h. Cell death was
confirmed by the uptake of trypan blue following the incubation of
the cultures with the dye [0.2 ml of a 0.4% trypan blue stock
solution (Gibco) was added to 1 ml of the extracellular medium]
for 10 min.
Calcium imaging
Intracellular calcium changes were monitored using the cell per-
meable AM ester form of the calcium fluorescent indicator
Oregon Green BAPTA-1. Cerebellar primary cultures were incu-
bated for 30 min at 37°C with Oregon Green BAPTA-1 and
pluronic acid (4 10−6 M each, Invitrogen), then washed for 30 min
at 37°C in the working solution, with or without drugs depending
on the experimental conditions used. An upright microscope
(Olympus BX51WI) was used to identify oligodendrocytes on the
basis of their typical morphology using a plan NEOFLUAR ×40
0.80 objective (Zeiss) in the DIC mode. Single-cell measure-
ments of [Ca2+]i changes were then performed by exciting intra-
cellular Oregon Green BAPTA-1 at 494 nm with a light-emitting
diode (Thorlabs) and recording the emitted fluorescence image at
590 nm using a CoolSNAP HQ2 camera (Photometrics), one
frame every 0.5 s throughout the experiments. We analysed fluo-
rescence in an ROI that covered the cell body of an
oligodendrocyte in a culture dish without overlapping neighbour-
ing cells. Dye excitation, image acquisitions and ROI analysis
protocols were performed using WinFluor image analysis soft-
ware (Strathclyde University). Relative changes in fluorescence
intensity were expressed as the ratio ΔF/F. ΔF/F = (F − F0)/
(F0 − B), where F is the measured fluorescence intensity of
Oregon Green, F0 the fluorescence intensity of the indicator in the
cell before stimulation (ET application), and B the background
signal determined in a ROI adjacent to the cell.
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Quantification of Purkinje cell myelination in
cultured slices
Myelination of the Purkinje cells in cerebellar organotypic slices
submitted to various treatments (ET and/or other drugs) was
evaluated on fixed (4% paraformaldehyde) slices by revealing
immunoreactivity against 28 kD protein (calbindin, to reveal
Purkinje cells and their processes as axons) and MBP (to mark
myelin). Confocal images (1024 × 1024, magnification of 20×,
pixel size = 757 nm) were acquired using 500–530 nm (green)
and 560–615 nm (red) filters. Non-overlapping ROI (100 × 100
pixels) were selected in the granule cell layer, just below the
Purkinje cell layer. As the myelin sheet wraps around axons,
28 kD protein and MBP signals cannot co-localize well. There-
fore, for each ROI and for each channel, the threshold of signal
intensity was adjusted to 10% of the maximum pixel intensity,
then the number of positive pixels for MBP (MBP+ pixels) and/or
28 kD protein (28 kD+ pixels) were counted.
Other materials
The following drugs were used at the indicated final concentra-
tion: Thapsigargin (0.5 10−6 M, Sigma-Aldrich), Dantrolene (1
10−5 M, Tocris), 2-APB (2-aminoethoxydiphenyl borate, 10−4 M,
Tocris), JNJ16259685 (2 10−6 M, Tocris), TBOA (threo-beta-
benzyloxyaspartate, 10−4 M and Tocris). All these drugs were
prepared as stock solutions diluted in dimethyl sulphoxide
(DMSO) in such a way that the final concentration of DMSO
in working solutions was < 0.1%. D-APV [(2R)-amino-5-
phosphonovaleric acid, 5 10−5 M, Ascent] and glutamate (10−5 or
10−6 M, Sigma-Aldrich) were dissolved extemporaneously in dis-
tilled water before dilution to the desired final concentrations in
the extracellular medium. Amphotericin B (AmB) and caffeine
were from Sigma.
Statistical analysis
Where necessary, results are presented as mean ± SE estab-
lished from the indicated number n of experiments. When data
are not normally distributed, their median is also reported. We
tested the statistical significance of the differences between two
conditions, using Student t-tests (normally distributed data) or the
Mann–Whitney test (not normally distributed data) for unpaired
set of data, and the paired t-test for paired data. For comparisons
of more than two conditions, statistical significance was tested
using analysis of variance (normally distributed data) or the
Kruskal–Wallis rank test (non-normally distributed data). P
value > 0.05 denotes no significant difference (n.s.). Significant P
is mentioned.
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